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Valproate is used in the treatment of patients with epi-
lepsy, focal fits, bipolar disorder, mood swings, and bipolar
disorder.1 Common adverse effects of valproate contain
headache, somnolence, insomnia, alopecia, nausea, vom-
iting, diarrhea, abdominal pain, dyspepsia, thrombocyto-
penia, and tremor.2,3 Herein, we describe a patient who
developed pleuropericardial effusion associated with the
use of valproate.
A 42-year-old woman was admitted to the internal
medicine department of our hospital due to dyspnea and
cough during the past 10 days. Her symptoms began 10
days prior to admission. Detailed medical history showed
that she had epilepsy that was treated for 2 years with
valproate 1250 mg/day for 6 years. Physical examination
of the chest revealed decreased breath sounds at the
middle and lower part of the left hemithorax. Standard
laboratory studies demonstrated mild anemia (hemoglo-
bin, 10.3 g/L), increased C-reactive protein (CRP,
5.1 mg/L), and erythrocyte sedimentation rate (ESR, 77).
Leukocytosis (10,000/mm3) and thrombocytosis (690,000/
mm3) were observed. Further laboratory investigation,* Corresponding author. Ankara Education and Research Hospital,
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ical tests, demonstrated no pathologies. Chest X-ray
showed a large left-sided pleural effusion (Fig. 1).Figure 1 Chest X-ray shows a large left-sided pleural
effusion.
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376 N. Tas‚er, M. SarıkayaEchocardiography had shown pericardial effusion and
pericardiocentesis was performed, during which 500 cc of
pericardial fluid was drained. Pericardial culture was
negative and neutrophilic transudative pericardial effu-
sion was detected. Diagnostic thoracentesis revealed a
neutrophilic transudative pleural effusion. After excluding
common reasons for pleuropericardial effusion, valproate
was discontinued and substituted with lamotrigine. Three
months later, pleuropericardial effusion was completely
ameliorated.
In the literature, most of the cases associated with
valproate are stated as having only pleural effusion and
these effusions are either eosinophilic or lymphocytic.4,5 In
this case, there has been pericardial effusion that is
neutrophilic and seen at the same time with pleural
effusion.
The approach to patients with pleuropericardial effusion
is difficult. After all other possible causative factors havebeen excluded, it is important to consider the possibility of
valproate-induced pleuropericardial effusion. In patients
using valproate, this adverse effect should be kept in mind.References
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